Products for Research Use Only

JZ19

CAT: 0804-HY-173005Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-173005Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JZ19 reduces the LDH and ROS levels, and exhibits antioxidant activity against oxygen-glucose deprivation (OGD) -induced cardiomyocyte injury. JZ19 reverses Isoproterenol -induced cardiomyocyte hypertrophy and apoptosis through PI3K-AKT-GSK3β signaling pathway. JZ19 alleviates Isoproterenol (HY-B0468) -induced heart failure in mouse models[1].
UNSPSC
12352005
Target
Akt; Apoptosis; GSK-3; PI3K
Related Pathways
Apoptosis; PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Cardiovascular Disease
Smiles
[H][C@@]1([C@@]2([C@@H](OC=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)[H])[C@@H]([C@H]4[C@@]2(O4)COC5=CC=C(C=C5)C(F)(F)F)O
Molecular Formula
C22H25F3O10
Molecular Weight
506.42
References & Citations
[1]Liu H, et al., Structure Optimization of Natural Product Catalpol to Obtain Novel and Potent Analogs against Heart Failure. J Med Chem. 2025 Feb 27;68 (4) :4540-4560.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
T206173-01JZ19